Datatrak Intl Inc (DTRK) 7.7500 $DTRK
Second Quarter 2016 Results Reported for DATATRAK International, Inc.
PR Newswire - Fri Aug 05, 2:01PM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the second quarter of 2016.
DATATRAK to Feature CTMS and Full Platform at Upcoming DIA 2016
PR Newswire - Thu Jun 16, 12:45PM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the full DATATRAK platform with an emphasis on the new CTMS solution, UX CTMS 360(TM), will be featured at DIA 2016.
Reduce Queries up to 90% with Integrated Imaging and EDC Technology
PR Newswire - Mon Jun 06, 7:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the completion of a case study analyzing the partnership between DATATRAK and AG Mednet to successfully reduce queries by 90% in a recent trial with integrated technology.
Jim Bob Ward Named CEO of DATATRAK
PR Newswire - Mon May 23, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced that interim CEO and founder of the software platform, Jim Bob Ward, has been named CEO and President.
DATATRAK International, Inc. Reports First Quarter Results of 2016
PR Newswire - Tue May 10, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the first quarter of 2016.
DATATRAK & NTT Data Host Tokyo User Group Meeting
Marketwired - Wed Feb 03, 4:10PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies, today announced its participation in the FIRST NTT Data User Group meeting held in Tokyo, Japan.
DATATRAK's Technology Driven Drug Development (TD3) Supports Clinical Trial Industry Transformation
Marketwired - Thu Jan 14, 11:06AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that more than 100 CROs, 10 of the top 15 pharmaceutical organizations, and 3 top 10 biotechs, are using the DATATRAK ONE UX(TM) platform in their efforts to harness technology to drive drug development.
Arosa Investment Management Thanks Datatrak Shareholders and Vows to Faithfully Represent Their Best Interests
BusinessWire - Wed Jan 13, 12:24PM CST
Arosa Investment Management LLC wishes to express its gratitude for the outpouring of support from a broad base of shareholders over the prolonged election process that spilled over into a new year, included three scheduled meeting dates and required shareholders to submit ballots at least twice. Here are the figures from IVS Associates' Final Report of the Inspector of Elections:
DATATRAK Welcomes New Directors
Marketwired - Tue Jan 12, 5:11PM CST
Three new directors have been elected to the board of DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry. Prior to the next meeting of the Board of Directors, the Company also reiterated its commitment to serving its customers and remains optimistic about the Company's long-term opportunity to grow and thrive in the future.
Statement From DATATRAK's Board Regarding Annual Meeting and the Call to Work Constructively Going Forward
Marketwired - Thu Jan 07, 1:09PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today released a statement from its three Class II Directors who will remain in office regardless of the results of tomorrow's Annual Meeting of Shareholders.
Arosa Investment Management Alerts Shareholders to the Datatrak Board's Secretive Adoption of Golden Parachutes and By-law Amendments
BusinessWire - Wed Jan 06, 7:16PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC
TRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, is alerting shareholders to the Datatrak board's secretive and shameless last-minute adoption of golden parachutes and by-law amendments.
DATATRAK Announces Settlement of Patent Litigation
Marketwired - Wed Jan 06, 8:02AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that it has entered into a settlement agreement with Medidata Solutions, Inc. to resolve all existing patent litigation between the parties.
Survey Says - DATATRAK Customer-Centric Approach Works
PR Newswire - Mon Jan 04, 9:32PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that results from an internal client survey confirm that DATATRAK's customer-centric approach to clinical trial solutions has had a positive impact.
Arosa Investment Management Again Refutes Datatrak's Shameless and Phony Campaign of Misinformation Targeted Against Arosa
BusinessWire - Mon Jan 04, 5:59PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTCTRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, again refutes Datatrak's shameless and phony campaign of misinformation targeted against Arosa.
DATATRAK Urges Shareholders To Reject Arosa's Claims
PR Newswire - Thu Dec 31, 3:23PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today called upon the shareholders to review the following information and reject Arosa's claims.
DATATRAK Technology and Clinical Research Expertise Bests Competitors
PR Newswire - Wed Dec 30, 7:53PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced top ranking content in the Clinical Leader Top 10 of 2015. A total of 5 DATATRAK authored articles were highlighted in the annual recap, more than any other source, with top spots in the White Paper and Case Study categories.
Arosa Investment Management Calls on Datatrak to Comply with Law and Stop Endless Delay and Entrenchment Actions; Calls on Chairman/CEO Larry Birch to Immediately Resign
BusinessWire - Wed Dec 30, 3:06PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTCTRK) that initiated a proxy contest and has now obtained the most votes at two scheduled Annual Meetings that Datatrak management has abruptly delayed, calls on Datatrak to immediately hold the 2015 Annual Meeting and calls on Chairman/CEO Larry Birch to immediately resign.
DATATRAK Uncovers Smoking Gun Evidence Tying Alex Tabatabai to Serious Misconduct
PR Newswire - Tue Dec 29, 8:45PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601.
DATATRAK Files Motion To Dismiss Arosa's Specious Claims Relating To The Postponed Annual Meeting
PR Newswire - Tue Dec 22, 7:00AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the Company has filed a motion to have the dissident's claims dismissed regarding previous postponement of the annual meeting.
Arosa Investment Management Vows to Work Productively with the Datatrak Board, Management and Other Constituencies
BusinessWire - Mon Dec 21, 2:29PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTCTRK) that initiated a proxy contest and obtained the most votes for Datatrak's originally scheduled 2015 Annual Meeting, today vowed that its three director nominees, when elected, will work productively with the Datatrak board, management and other constituencies of the company.
Second Quarter 2016 Results Reported for DATATRAK International, Inc.
PR Newswire - Fri Aug 05, 2:01PM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the second quarter of 2016.
DATATRAK to Feature CTMS and Full Platform at Upcoming DIA 2016
PR Newswire - Thu Jun 16, 12:45PM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the full DATATRAK platform with an emphasis on the new CTMS solution, UX CTMS 360(TM), will be featured at DIA 2016.
Reduce Queries up to 90% with Integrated Imaging and EDC Technology
PR Newswire - Mon Jun 06, 7:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the completion of a case study analyzing the partnership between DATATRAK and AG Mednet to successfully reduce queries by 90% in a recent trial with integrated technology.
Jim Bob Ward Named CEO of DATATRAK
PR Newswire - Mon May 23, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced that interim CEO and founder of the software platform, Jim Bob Ward, has been named CEO and President.
DATATRAK International, Inc. Reports First Quarter Results of 2016
PR Newswire - Tue May 10, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the first quarter of 2016.
DATATRAK & NTT Data Host Tokyo User Group Meeting
Marketwired - Wed Feb 03, 4:10PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies, today announced its participation in the FIRST NTT Data User Group meeting held in Tokyo, Japan.
DATATRAK's Technology Driven Drug Development (TD3) Supports Clinical Trial Industry Transformation
Marketwired - Thu Jan 14, 11:06AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that more than 100 CROs, 10 of the top 15 pharmaceutical organizations, and 3 top 10 biotechs, are using the DATATRAK ONE UX(TM) platform in their efforts to harness technology to drive drug development.
Arosa Investment Management Thanks Datatrak Shareholders and Vows to Faithfully Represent Their Best Interests
BusinessWire - Wed Jan 13, 12:24PM CST
Arosa Investment Management LLC wishes to express its gratitude for the outpouring of support from a broad base of shareholders over the prolonged election process that spilled over into a new year, included three scheduled meeting dates and required shareholders to submit ballots at least twice. Here are the figures from IVS Associates' Final Report of the Inspector of Elections:
DATATRAK Welcomes New Directors
Marketwired - Tue Jan 12, 5:11PM CST
Three new directors have been elected to the board of DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry. Prior to the next meeting of the Board of Directors, the Company also reiterated its commitment to serving its customers and remains optimistic about the Company's long-term opportunity to grow and thrive in the future.
Statement From DATATRAK's Board Regarding Annual Meeting and the Call to Work Constructively Going Forward
Marketwired - Thu Jan 07, 1:09PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today released a statement from its three Class II Directors who will remain in office regardless of the results of tomorrow's Annual Meeting of Shareholders.
Arosa Investment Management Alerts Shareholders to the Datatrak Board's Secretive Adoption of Golden Parachutes and By-law Amendments
BusinessWire - Wed Jan 06, 7:16PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC
TRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, is alerting shareholders to the Datatrak board's secretive and shameless last-minute adoption of golden parachutes and by-law amendments. DATATRAK Announces Settlement of Patent Litigation
Marketwired - Wed Jan 06, 8:02AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that it has entered into a settlement agreement with Medidata Solutions, Inc. to resolve all existing patent litigation between the parties.
Survey Says - DATATRAK Customer-Centric Approach Works
PR Newswire - Mon Jan 04, 9:32PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that results from an internal client survey confirm that DATATRAK's customer-centric approach to clinical trial solutions has had a positive impact.
Arosa Investment Management Again Refutes Datatrak's Shameless and Phony Campaign of Misinformation Targeted Against Arosa
BusinessWire - Mon Jan 04, 5:59PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC
TRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, again refutes Datatrak's shameless and phony campaign of misinformation targeted against Arosa. DATATRAK Urges Shareholders To Reject Arosa's Claims
PR Newswire - Thu Dec 31, 3:23PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today called upon the shareholders to review the following information and reject Arosa's claims.
DATATRAK Technology and Clinical Research Expertise Bests Competitors
PR Newswire - Wed Dec 30, 7:53PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced top ranking content in the Clinical Leader Top 10 of 2015. A total of 5 DATATRAK authored articles were highlighted in the annual recap, more than any other source, with top spots in the White Paper and Case Study categories.
Arosa Investment Management Calls on Datatrak to Comply with Law and Stop Endless Delay and Entrenchment Actions; Calls on Chairman/CEO Larry Birch to Immediately Resign
BusinessWire - Wed Dec 30, 3:06PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC
TRK) that initiated a proxy contest and has now obtained the most votes at two scheduled Annual Meetings that Datatrak management has abruptly delayed, calls on Datatrak to immediately hold the 2015 Annual Meeting and calls on Chairman/CEO Larry Birch to immediately resign. DATATRAK Uncovers Smoking Gun Evidence Tying Alex Tabatabai to Serious Misconduct
PR Newswire - Tue Dec 29, 8:45PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601.
DATATRAK Files Motion To Dismiss Arosa's Specious Claims Relating To The Postponed Annual Meeting
PR Newswire - Tue Dec 22, 7:00AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the Company has filed a motion to have the dissident's claims dismissed regarding previous postponement of the annual meeting.
Arosa Investment Management Vows to Work Productively with the Datatrak Board, Management and Other Constituencies
BusinessWire - Mon Dec 21, 2:29PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC
TRK) that initiated a proxy contest and obtained the most votes for Datatrak's originally scheduled 2015 Annual Meeting, today vowed that its three director nominees, when elected, will work productively with the Datatrak board, management and other constituencies of the company. 
